| Aβ | Amyloid beta |
| AC | Adenylate cyclase |
| AD | Alzheimer’s disease |
| ADP | Adenosine diphosphate |
| ALS | Amyotrophic lateral sclerosis |
| AR | Adenosine receptor |
| ATP | Adenosine triphosphate |
| BBB | Blood-brain barrier |
| cAMP | Cyclic adenosine monophosphate |
| CD39 | Cluster differentiation 39 |
| CX3CL1 | C-X3-C motif chemokine ligand |
| CX3CR1 | C-X3-C motif chemokine receptor 1 |
| Cys | Cysteine |
| EAE | Experimental autoimmune encephalomyelitis |
| ERK | Extracellular signal-regulated kinase |
| GPCR | G protein-coupled receptor |
| IL | Interleukin |
| KO | Knockout |
| OGD | Oxygen-glucose deprivation |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MPC | Microglial process convergence |
| mRNA | Messenger ribonucleic acid |
| MS | Multiple sclerosis |
| NLRP3 | Nod-like receptor protein 3 |
| PI3K | Phosphoinositide 3-kinase |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PLC | Phospholipase C |
| siRNA | Silent ribonucleic acid |
| SOD1 | Superoxide dismutase 1 |
| TBI | Traumatic brain injury |
| THIK-1 | TWIK-related halothane-inhibited K+ channel |
| UDP | Uridine diphosphate |
| UTP | Uridine triphosphate |
| VASP | Vasodilator-stimulated phosphoprotein |
| WT | Wild-type |